Retrospective analysis of capecitabine and oxaliplatin (XELOX) plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer

XELOX plus bevacizumab is an effective treatment strategy and has a manageable tolerability profile when administered to Japanese patients with metastatic colorectal cancer (mCRC). In this study, we retrospectively reviewed cases in which XELOX plus bevacizumab were administered in order to evaluate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: UCHIMA, YASUTAKE, NISHII, TAKAFUMI, ISEKI, YASUHITO, ISHII, MARIKO, HIRAMATSU, SOICHIRO, IWAUCHI, TAKEHIKO, MORIMOTO, JUNYA, KOSAKA, KINSHI, TEI, SEIKA, TAKEUCHI, KAZUHIRO
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3915698/
https://ncbi.nlm.nih.gov/pubmed/24649322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2013.205
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares